Clinical Trial Update: This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy. [Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 2 study from Hebei Medical University Fourth Hospital to optimize neoadjuvant therapy for HER2-positive breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: HER2-positive Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING